Objective: To evaluate the baseline predictors of long-term all-cause-and cardiovascular (CV)-mortality amongst high-risk hypertensive patients, and to develop an integer-based risk score.
Results: During median follow-up of 15.7 years, 3282 (38.3%) of 8580 hypertensive patients (mean age at baseline, 64.1 year) died with about a third (n, 1210) from CV-related causes. Figure 1 lists the baseline predictors signifi cantly associated with all-cause-and CV-mortality. Aside from increasing age and smoking status, increasing baseline levels of fasting plasma glucose and serum creatinine, presence of atrial fi brillation and previous history of peripheral-or cerebrovascular-disease were signifi cant risk factors for 2 outcomes. Notably, increase in pulse pressure (PP) (and not SBP) was an independent risk factor, with 47% and 53% signifi cantly higher risk for all-cause and CV-mortality amongst those with PP > = 100 (vs. PP < 60), respectively. BMI and alcohol intake were signifi cantly associated with all-cause-(but not CV-) mortality: BMI < 20 kg/m2, and alcohol intake > 28 units/week were associated with 79% and 20% increased risk respectively. Higher SES was associated with a signifi cantly reduced risk for both outcomes. Both models had an excellent discriminative ability (c-statistics, 0.72 and 0.73, respectively).
Conclusions:
Our fi ndings suggest that a few baseline determinants in our 2 models are different from those that are routinely used for CV-risk prediction. Particularly, increase in baseline PP (and not SBP) was found to be an independent and better predictor for both all-cause and CV-mortality in this high-risk hypertensive population.
POPULATION ATTRIBUTABLE RISK FOR CARDIOVASCULAR DISEASE ASSOCIATED WITH HYPERTENSION. RESULTS FROM THE HORTEGA FOLLOW-UP STUDY
A. Objective: Hypertension (HTN) is the worldwide leading risk factor for cardiovascular morbidity and mortality. As a modifi able risk factor, epidemiological measures derived from cohort studies are important to infl uence policymakers.
Objective:
To determine the population attributable risk (PAR) for cardiovascular disease associated with hypertension.
Design and method:
We included 1244 subjects (mean age 52.3 y, 51% females), who participated in Hortega 13 years Follow-Up Study. HTN was defi ned as a blood pressure greater than or equal to 140/90 mmHg for systolic and diastolic blood pressure or the use of antihypertensive medication. We used Cox proportional hazard analysis adjusted for traditional CVD risk factors to determine the association of HTN with incident CVD cases. The primary endpoint was incidence of fatal and non-fatal CV events. Due to the presence of confounding factors, the PAR was calculated as pd*(HR 1)/HR and 95% confi dence interval was calculated using Bonferroni inequality method. Hazard Ratio (HR) estimates and HTN prevalence among cases (pd) were used to calculate sex-specifi c PARs for heart failure (HF), coronary heart disease (CHD) and stroke.
Results: In our population, overall prevalence of hypertension was 34.7% (n = 211) and 34.1% (n = 217) for men and women, respectively. The HR for all CVD and the PAR associated with HTN was 1.89 (95% CI 1.63, 2.18) and 33.1 (95% CI 22.1, 43.8) respectively in men and 1.71 (95% CI 1.4, 2.09) and 33.8 (95% CI 19.4, 47) in women. The HR for CHD plus stroke and PAR associated with HTN was 1.7 (95% CI 1.42, 2.02) and 27.3 (95% CI 14.7, 40.6) in men and 1.91 (95% CI 1.48, 2.46) and 38.3 (95% CI 19.4, 54.6) in women. The HR for HF and PAR associated with HTN was 3.2 (95% CI 2.11, 4.83) and 57.4 (95% CI 31.3, 75) in men and 3.97 (95% CI 2.4, 6.56) and 69.4 (95% CI 41.6, 83.5) in women.
Conclusions:
In our population, approximately 33% of incident CVD is attributable to hypertension. This study emphasizes the role of hypertension as agent in different cardiovascular diseases, with a burden of up to 70% in women with heart failure.
